The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer.

T cell T‑cell receptor variable β clonotype frequencies prostate cancer radiation therapy

Journal

International journal of oncology
ISSN: 1791-2423
Titre abrégé: Int J Oncol
Pays: Greece
ID NLM: 9306042

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 27 01 2022
accepted: 24 03 2022
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 23 4 2022
Statut: ppublish

Résumé

Radiation therapy (RT) is an essential component in the therapeutic treatment of patients with localized prostate cancer (LPCa). Besides its local effects, ionizing radiation has been linked to mechanisms leading to systemic immune activation. The present study explored the effect of RT on the T‑cell receptor variable β (TCR Vβ) chain repertoire of peripheral blood T cells in patients with LPCa. High‑throughput TCR Vβ sequencing was performed on 20 blood samples collected from patients with LPCa at baseline and 3 months post‑RT. The diversity index was altered, as were TCR Vβ clonal evenness and convergence before and post‑RT; however, these findings were not significant. Notably, marked changes in the frequencies among the top 10 TCR Vβ clonotypes were detected and some patients developed new clonotypes of high abundance. These data provided initial evidence that RT in patients with LPCa may induce systemic immune changes, which could be exploited by future therapies for improved clinical results.

Identifiants

pubmed: 35445738
doi: 10.3892/ijo.2022.5361
pii: 71
pmc: PMC9084611
doi:
pii:

Substances chimiques

Receptors, Antigen, T-Cell, alpha-beta 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Cancer Discov. 2017 Oct;7(10):1088-1097
pubmed: 28733428
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23721-23729
pubmed: 32900949
Trends Pharmacol Sci. 2007 Sep;28(9):465-72
pubmed: 17692395
Cell. 2014 May 22;157(5):1073-87
pubmed: 24855945
Radiat Res. 2010 Apr;173(4):418-25
pubmed: 20334513
FEBS Open Bio. 2019 Aug;9(8):1450-1459
pubmed: 31237075
Nat Immunol. 2003 Mar;4(3):241-7
pubmed: 12563259
J Immunol. 2008 Sep 1;181(5):3099-107
pubmed: 18713980
Thorac Cancer. 2019 Jul;10(7):1605-1611
pubmed: 31228354
Adv Exp Med Biol. 2018;1096:31-47
pubmed: 30324346
Clin Cancer Res. 2007 Mar 1;13(5):1493-502
pubmed: 17332294
Nature. 2017 Jan 19;541(7637):359-364
pubmed: 28068672
Bioinformatics. 2007 Nov 1;23(21):2947-8
pubmed: 17846036
J Clin Med. 2021 Oct 31;10(21):
pubmed: 34768644
Vaccine. 2015 Dec 16;33(51):7415-7422
pubmed: 26148880
Annu Rev Immunol. 2009;27:229-65
pubmed: 19302040
Immunity. 2014 Nov 20;41(5):843-52
pubmed: 25517616
Prostate Cancer Prostatic Dis. 2005;8(4):353-8
pubmed: 16158079
Clin Cancer Res. 2008 Aug 1;14(15):4883-90
pubmed: 18676762
Nature. 2017 Jul 6;547(7661):94-98
pubmed: 28636589
Nature. 2013 Jun 20;498(7454):380-4
pubmed: 23722158
Cancer Immunol Immunother. 2014 Mar;63(3):259-71
pubmed: 24357146
BMC Urol. 2021 Feb 25;21(1):29
pubmed: 33632199
Clin Cancer Res. 2017 Sep 15;23(18):5514-5526
pubmed: 28533222
Cancers (Basel). 2021 Jun 12;13(12):
pubmed: 34204662
Front Immunol. 2021 Oct 18;12:719285
pubmed: 34733273
Nat Med. 2018 Dec;24(12):1845-1851
pubmed: 30397353
Nat Commun. 2021 Jul 2;12(1):4098
pubmed: 34215730
Cancer Res. 2011 Apr 1;71(7):2488-96
pubmed: 21300764
Nat Commun. 2017 Jun 09;8:15618
pubmed: 28598415
N Engl J Med. 2012 Mar 8;366(10):925-31
pubmed: 22397654
Nature. 2009 Oct 8;461(7265):788-92
pubmed: 19776740
Front Oncol. 2019 Nov 22;9:1287
pubmed: 31824860
Science. 2013 Feb 15;339(6121):786-91
pubmed: 23258413
Cancer Res. 2010 Apr 1;70(7):2697-706
pubmed: 20215523
Oncol Lett. 2018 Feb;15(2):1744-1752
pubmed: 29399194
Bioinformatics. 2019 May 1;35(9):1461-1468
pubmed: 30247624
Nature. 2015 Apr 16;520(7547):373-7
pubmed: 25754329
Curr Opin Urol. 2018 Jan;28(1):15-24
pubmed: 29095729
Trends Immunol. 2018 Aug;39(8):644-655
pubmed: 30001871
Immunotherapy. 2019 Feb;11(2):69-74
pubmed: 30727800
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):21-34
pubmed: 30836165
Nat Immunol. 2016 Aug;17(8):946-55
pubmed: 27348411

Auteurs

Maria Goulielmaki (M)

Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Nikolaos Davanos (N)

ANTISEL S.A., 11527 Athens, Greece.

Paraskevi Kogionou (P)

Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Panagiota Batsaki (P)

Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Savvas Stokidis (S)

Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Maria Adamaki (M)

Biomedical Applications Unit, Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.

Eftychia Mosa (E)

Department of Radiation Oncology, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Evanthia Vasilakou (E)

Department of Radiation Oncology, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Charalambos Zambatis (C)

Department of Radiation Oncology, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Angelos D Gritzapis (AD)

Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Vassilios Zoumpourlis (V)

Biomedical Applications Unit, Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.

Constantin N Baxevanis (CN)

Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Sotirios P Fortis (SP)

Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH